Intelligent Bio Solutions Inc. Common Stock (INBS) is a publicly traded Healthcare sector company. As of September 9, 2026, INBS trades at $2.20 with a market cap of $6.75M and a P/E ratio of -0.26. INBS moved +0.00% today. Year to date, INBS is -77.44%; over the trailing twelve months it is -86.93%. Its 52-week range spans $1.52 to $27.50. Rallies surfaces INBS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for INBS, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $2.20 |
| Market Cap | $6.75M |
| P/E Ratio | -0.26 |
| EPS | $-8.44 |
| Dividend Yield | 0.00% |
| 52-Week High | $27.50 |
| 52-Week Low | $1.52 |
| Volume | 15.33K |
| Avg Volume | 0 |
| Revenue (TTM) | $4.22M |
| Net Income | $-12.47M |
| Gross Margin | 48.63% |
INBS analyst coverage data. Average price target: $0.00.